220 related articles for article (PubMed ID: 12423841)
1. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.
Lindenfeld EA; Langer RD
Obstet Gynecol; 2002 Nov; 100(5 Pt 1):853-63. PubMed ID: 12423841
[TBL] [Abstract][Full Text] [Related]
2. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.
Greendale GA; Reboussin BA; Hogan P; Barnabei VM; Shumaker S; Johnson S; Barrett-Connor E
Obstet Gynecol; 1998 Dec; 92(6):982-8. PubMed ID: 9840563
[TBL] [Abstract][Full Text] [Related]
3. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Langer RD; Landgren BM; Rymer J; Helmond FA;
Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
[TBL] [Abstract][Full Text] [Related]
4. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
5. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
[TBL] [Abstract][Full Text] [Related]
7. Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
Clisham PR; de Ziegler D; Lozano K; Judd HL
Obstet Gynecol; 1991 Feb; 77(2):241-6. PubMed ID: 1846438
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
[TBL] [Abstract][Full Text] [Related]
9. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Archer DF; Pickar JH; Bottiglioni F
Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
[TBL] [Abstract][Full Text] [Related]
10. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
Espeland MA; Marcovina SM; Miller V; Wood PD; Wasilauskas C; Sherwin R; Schrott H; Bush TL
Circulation; 1998 Mar; 97(10):979-86. PubMed ID: 9529266
[TBL] [Abstract][Full Text] [Related]
11. Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.
Kagan R; Abreu P; Andrews E
Postgrad Med; 2018 Nov; 130(8):687-693. PubMed ID: 30280946
[TBL] [Abstract][Full Text] [Related]
12. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques.
Cline JM; Soderqvist G; von Schoultz E; Skoog L; von Schoultz B
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):93-100. PubMed ID: 8572040
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
[TBL] [Abstract][Full Text] [Related]
14. The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.
Barrett-Connor E; Slone S; Greendale G; Kritz-Silverstein D; Espeland M; Johnson SR; Waclawiw M; Fineberg SE
Maturitas; 1997 Jul; 27(3):261-74. PubMed ID: 9288699
[TBL] [Abstract][Full Text] [Related]
15. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement.
Williams DB; Voigt BJ; Fu YS; Schoenfeld MJ; Judd HL
Obstet Gynecol; 1994 Nov; 84(5):787-93. PubMed ID: 7936513
[TBL] [Abstract][Full Text] [Related]
16. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
17. Sleep in menopause: differential effects of two forms of hormone replacement therapy.
Montplaisir J; Lorrain J; Denesle R; Petit D
Menopause; 2001; 8(1):10-6. PubMed ID: 11201509
[TBL] [Abstract][Full Text] [Related]
18. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
Espeland MA; Hogan PE; Fineberg SE; Howard G; Schrott H; Waclawiw MA; Bush TL
Diabetes Care; 1998 Oct; 21(10):1589-95. PubMed ID: 9773716
[TBL] [Abstract][Full Text] [Related]
19. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.
Archer DF; Dorin M; Lewis V; Schneider DL; Pickar JH
Fertil Steril; 2001 Jun; 75(6):1080-7. PubMed ID: 11384630
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.
Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E
Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
